Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib. Tumor lysis syndrome induced by low-dose steroid...

Full description

Bibliographic Details
Main Authors: Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2015-03-01
Series:Clinical and Molecular Hepatology
Subjects:
Tumor lysis syndrome
Hepatocellular carcinoma
Steroid
Online Access:http://e-cmh.org/upload/pdf/cmh-21-85.pdf

Similar Items

Similar Items